← Back to patent-cliff list
SJ-557733
Tier C — Watch / tradeSJ-557733
Medicines for Malaria Venture
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：ATP2A1
Indications (approved)：间日疟原虫感染, Plasmodium infection, Falciparum malaria
Regional status
US
No progress
2016-03-01
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of SJ-557733?
Approved indications include: 间日疟原虫感染, Plasmodium infection, Falciparum malaria.
When does the SJ-557733 patent expire?
No public expiry year is available for SJ-557733 yet; this page updates once verified.
How do I get a quote for SJ-557733 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06